<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01415700</url>
  </required_header>
  <id_info>
    <org_study_id>P070155</org_study_id>
    <secondary_id>2007-A01444-49</secondary_id>
    <nct_id>NCT01415700</nct_id>
  </id_info>
  <brief_title>Comparison Between Implanted Functional Electrical Stimulation and Foot Orthosis</brief_title>
  <acronym>STEPSTIM</acronym>
  <official_title>Implanted Functional Electrical Stimulation of the Levators of the Ankle Versus Orthosis in the Treatment of Chronic Foot Neurological STEPPAGE-gait by Central Attack</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Assistance Publique - Hôpitaux de Paris</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Assistance Publique - Hôpitaux de Paris</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The implantable feet stimulator proposes to correct the feet's STEPPAGE observed after&#xD;
      central nervous system's injury such as hemiplegia secondary to stroke. It aims to improve&#xD;
      the patient's walking floor by removing the STEPPAGE, reducing the effort of walking,&#xD;
      facilitating the flow and removing anomalies compensatory (such as the mowing of the hip).&#xD;
      Its objective is to improve the patient's autonomy locomotor.&#xD;
&#xD;
      The aim of this study is to compare the results of the implementation of an implanted&#xD;
      stimulator in the levator muscles of the foot to the results obtained by wearing a&#xD;
      splint-type reliever, which is considered standard treatment, in order to determine if the&#xD;
      implanted stimulation may be proposed in the treatment of foot drop off a neurological&#xD;
      center.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The implantable feet stimulator proposes to correct the feet's STEPPAGE observed after&#xD;
      central nervous system's injury such as hemiplegia secondary to stroke. It aims to improve&#xD;
      the patient's walking floor by removing the STEPPAGE, reducing the effort of walking,&#xD;
      facilitating the flow and removing anomalies compensatory (such as the mowing of the hip).&#xD;
      Its objective is to improve the patient's autonomy locomotor.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>October 2010</start_date>
  <completion_date type="Actual">January 2014</completion_date>
  <primary_completion_date type="Actual">October 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Measurement of walking speed at 3 months</measure>
    <time_frame>Measurement will be performed at 3 months</time_frame>
    <description>The measurement is taken for a spontaneous march floor then fast. It follows from the establishment of the average of 3 to 5 passes on a walking track of a platform for analysis of movement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Measurement of walking speed at 6 months</measure>
    <time_frame>Measurement will be performed at 6 months</time_frame>
    <description>The measurement is taken for a spontaneous march floor then fast. It follows from the establishment of the average of 3 to 5 passes on a walking track of a platform for analysis of movement</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">27</enrollment>
  <condition>Hysterical Simulation of Disease</condition>
  <arm_group>
    <arm_group_label>Stimulator</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Orthosis</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Functional electrical stimulator</intervention_name>
    <description>The stimulator is surgically implanted</description>
    <arm_group_label>Stimulator</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>feet orthosis</intervention_name>
    <description>feet orthosis specifically mold</description>
    <arm_group_label>Orthosis</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  STEPPAGE foot walking in a patient with a central neurological disease&#xD;
&#xD;
          -  can walk for 50 meters with or without technical assistance&#xD;
&#xD;
          -  stable disease for at least 1 year&#xD;
&#xD;
          -  possible walk with a brace-type reliever&#xD;
&#xD;
          -  verification of possible nerve stimulation&#xD;
&#xD;
          -  age greater than or equal to 18 years and under 75 years&#xD;
&#xD;
          -  no toxin for 4 months&#xD;
&#xD;
          -  no alcohol for 6 months&#xD;
&#xD;
          -  no neurotomy for 1 year&#xD;
&#xD;
          -  patient who agreed to sign an informed consent to participate in the study&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  cons-indication to general anesthesia&#xD;
&#xD;
          -  wearing a stimulator implanted for other reasons&#xD;
&#xD;
          -  patients taking neuroleptics, benzodiazepines, or antidepressants or other drugs that&#xD;
             interfere with the quality of walking&#xD;
&#xD;
          -  advanced peripheral neuropathy&#xD;
&#xD;
          -  excessive restriction of passive range of ankle&#xD;
&#xD;
          -  poorly controlled epilepsy&#xD;
&#xD;
          -  pregnant or lactating&#xD;
&#xD;
          -  non-membership of a social security scheme&#xD;
&#xD;
          -  wearing orthopaedic shoes including the malleolus&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Philippe Decq, PUPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Assistance Publique - Hôpitaux de Paris</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Henri Mondor Hospital</name>
      <address>
        <city>Creteil</city>
        <zip>94010</zip>
        <country>France</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2014</verification_date>
  <study_first_submitted>August 8, 2011</study_first_submitted>
  <study_first_submitted_qc>August 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">August 12, 2011</study_first_posted>
  <last_update_submitted>July 25, 2014</last_update_submitted>
  <last_update_submitted_qc>July 25, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 28, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>feet STEPPAGE of central neurological origin</keyword>
  <keyword>implanted functional electrical stimulation</keyword>
  <keyword>feet orthosis</keyword>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

